Treatment of whitish or yellowish vaginal discharge with Unani medicine Tiryaq e Reham

Phase 3

Not yet recruiting

• Conditions: Noninflammatory disorder of vagina, unspecified,

• Registration Number: CTRI/2023/03/050475
• Lead Sponsor: Central Council for Research in Unani Medicine CCRUM New Delhi

Brief Summary

This study is designed as a single centric open trial in patients with Sailan ur Reham (Leucorrhoea)**.**After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically at every week for two weeks. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 2 weeks. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.

**Compositionof Tiryaq e Reham**

| | | |

| --- | --- | --- |

|1

Gul e Supari

40 gms

|2

Gul e pista

40 gms

|3

Simagh dhak

40 gms

|4

Inderjo shireen

20 gms

|5

Asgand nagoori

20 gms

|6

Kushta qalai

3  gms

|7

Kushta marjan

3  gms

|8

Kushta aqeeq

1.5 gms

|9

Misri

80  gms

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-07-03
• Study Start: 2023-10-03

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 384

Inclusion Criteria

• Female patients in the age group of 13-45 years.
• Patients having excessive vaginal discharge with or without any of the following associated symptoms • Waja ‘al-Zahr (Backache) • Naqahat (General Weakness).

Exclusion Criteria

• Patients having acute / Chronic PIDs 2.
• Unexplained vaginal bleeding 3.
• Abnormal findings on pelvic sonography 4.
• Systemic disease like hypertension, diabetes, heart disease, tuberculosis, 5.
• Patients on Oral Contraceptives / IUDs. 7.
• Patients taking hormonal therapy.
• Any abnormality on pv Examination.
• Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in sign and symptoms of Sailan ur Reham (Leucorrhoea) i.e. Amount of Vaginal Discharge (scoring according to the semi quantitative method), Waja ‘al-Zahr (backache), Naqahat (General Weakness) and improvement in abnormal findings of vaginal smear	At baseline, 7th day and 14th day

Secondary Outcome Measures

Name	Time	Method
Haematological and biochemical assessment for safety assessment	On baseline and 14th day

Trial Locations

Locations (1)

Regional Research Institute of Unani Medicine, Chennai; 🇮🇳 Chennai, TAMIL NADU, India

Regional Research Institute of Unani Medicine, Chennai

🇮🇳Chennai, TAMIL NADU, India

Dr A Farhath Fathima

Principal investigator

9941767447

farhathcrony@gmail.com